PPWE, PWRM, TRH, LXK, APU -BY STOCK-PR.COM

 

Stock-PR Reporting

 

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

Proper Power & Energy, Inc. (Board:PPWE.PK) announced today that its wholly owned subsidiary, American Resources, Inc. (ARI), has begun production on its 87.5 acres in Western Kentucky.

ARI has completed the re-work on all 4 wells, with those wells online and pumping. “This is an exciting day for us,” stated Proper Power President, Andrew Kacic. “This is the beginning of production for Proper Power in Kentucky, and we look forward to increasing our presence.”

Proper Power & Energy, Inc. (OTC:PPWE) just recently reported that it has restructured its executive management team and entered into a strategic alliance.

Andrew J. Kacic will replace Joseph Abdo as President of Proper Power & Energy. Mr. Kacic brings more than 32 years of progressive experience as a chief executive in oil and gas, investment banking, insurance services and public securities. Mr. Kacic was the founder and president of American Resources of Delaware, Inc. and its subsidiary Southern Gas Company, successfully taking assets from $220,000 to more than $40 million in less than 4 years. Mr. Abdo will remain the Chief Executive Officer and Chairman of the Board.

Concurrently to the management restructuring, the Company has entered into a strategic alliance with Douglas Kiggins, founder of Mayo Energy Partners. Mr. Kiggins will assist Mr. Kacic in the development of the Company’s Utah asset, with the target goal of drilling the first exploratory well in Utah by third Quarter 2011. Mr. Kiggins has participated in the drilling and development of over 250 oil and gas wells in Texas, Oklahoma and Colorado, with the deepest well reaching a total depth over 21,000 feet.

“The Company is now postured to accelerate the development of both Utah and Kentucky in the first Quarter 2011,” Mr. Abdo stated.

About Proper Power & Energy:

Proper Power & Energy was formed in 2006 as an exploration and production company for oil and gas. The organization is committed to utilizing a very dynamic system of research and testing, and as a result of this extensive research and testing, have selected several sites with very good to excellent potential for productivity.

Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.

“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

Alzheimer’s declines ultimately. Alzheimer’s is a progressing sickness, in which symptoms gradually worsen over a period of time. Continuing, memory loss is minor, but with late-stage Alzheimer’s, people will not be able to hold on a conversation and respond to their natural environment. Alzheimer’s disease is the 6th major cause of loss of life in the USA. Some people that have Alzheimer’s live life an average of eight years after their indications come to be noticeable to other people, but survival can range from 3 to 20 years, based on maturity and various health conditions.

Breast cancer (malignant breast neoplasm) is actually cancer originating from breast tissue, most commonly of your intrinsic lining of milk ducts as well as lobules that offer the ducts with milk. Cancers caused by ducts are classified as ductal carcinomas; individuals originating from lobules are classified as lobular carcinomas.

Parkinson’s disease generally affects people around 50 years old. Early on warning signs of PD are subtle and take place gradually. Inside many people the ailment moves along faster compared with others. Since the ailment moves on, the shaking, or tremor, which in turn impinges on a large number of PD patients can start to impact every day actions. Other signs and symptoms may include depression and other mental adjustments; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. Generally there are currently no blood or laboratory tests which may help in figuring out sporadic PD. Because of this the medical diagnosis is depending on track record including a neurological examination. The actual condition can be hard to diagnose properly. Doctors may possibly sometimes demand brain scans or laboratory tests as a way to eliminate other diseases.

Transatlantic Holdings Inc. (NYSE:TRH) will announce its fourth quarter 2010 results after the close of trading on the NYSE on Wednesday, February 9, 2011. A copy of the earnings release and a financial supplement will be available in the Investor Information section of the Company’s website located at www.transre.com. The Company will host a conference call to discuss its fourth quarter 2010 results on Thursday, February 10, 2011 beginning at 11:00 a.m. Eastern Time.
Transatlantic Holdings, Inc., through its subsidiaries, offers reinsurance capacity for a range of property and casualty products, directly and through brokers, to insurance and reinsurance companies, in domestic and international markets.

Lexmark International Inc. (NYSE:LXK) announced fourth quarter 2010 earnings on Tuesday, February 1, 2011. A conference call is scheduled for 8:30 a.m. EST. The live audio broadcast can be accessed from Lexmark's investor relations Web site at http://investor.lexmark.com. A replay will be available on the investor relations Web site shortly after the call. Lexmark International, Inc. (NYSE:LXK) provides businesses of all sizes with a broad range of printing and imaging products, software, solutions and services that help customers to print less and save more.
Lexmark International, Inc. develops, manufactures, and supplies printing and imaging solutions for offices. It offers laser printers, inkjet printers, and multifunction devices, as well as cartridges and other supplies, services, and solutions.

AmeriGas Partners LP (NYSE:APU) will hold a live Internet Audio Webcast of its conference call to discuss first quarter earnings and other current activities at 4:00 PM ET on Wednesday, January 26. A telephonic replay will be available from 7:00 PM ET on January 26 through midnight Friday, January 28. The replay may be accessed at 1-800-642-1687, passcode 67803304 and International access 1-706-645-9291, passcode 67803304.
AmeriGas Partners, L.P., through its subsidiary, AmeriGas Propane, L.P., operates as a retail propane distributor in the United States.

 

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates receiving 1,000,000 shares of free trading shares from a third party (Mohamad Nehmeh) for two (2) weeks of advertisment services for Proper Power & Energy, Inc. (OTC:PPWE). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

 

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

________________________________________

Be Sure To Visit stock-pr.ning.com

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.